HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers

Author： Manzo-Merino Joaquin Thomas Miranda Fuentes-Gonzalez Alma M Lizano Marcela Banks Lawrence

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.11, 2013-11, pp. : 1357-1368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers

By Hosseinzadeh Sahar

Drug Delivery, Vol. 20, Iss. 3-4, 2013-04 ,pp. : 190-198

Informa Healthcare

Access to resources Recommend Favorite

HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1379-1394

Bentham Science Publishers

Access to resources Recommend Favorite

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

Current Medicinal Chemistry, Vol. 24, Iss. 32, 2017-10 ,pp. : 3485-3507

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 170-184

Bentham Science Publishers

Access to resources Recommend Favorite

HPV-related noncervical disease exerts massive burden

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 554, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite